Cover Image

Clinical and economic analysis of using dapagliflozin in patients with chronic kidney disease in the Russian Federation

Aim. To evaluate the clinical and economic efficiency of the use of dapagliflozin in patients with chronic kidney disease (CKD) stages 24 in Russian Federation. Materials and methods. Cost-effectiveness (utility) analysis has been carried out. Mathematical model has been developed, adapted to the he...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sergey V. Nedogoda (Author), Alla S. Salasyuk (Author), Irina N. Barykina (Author), Viktoria O. Smirnova (Author), Ekaterina A. Popova (Author)
Format:	Book
Published:	ZAO "Consilium Medicum", 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacoeconomic analysis of dapagliflozin in patients with chronic kidney disease and type 2 diabetes in the Russian Federation
by: Sergey V. Nedogoda, et al.
Published: (2024)

COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN
by: V. I. Petrov, et al.
Published: (2016)

Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020)

Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma
by: S. V. Nedogoda, et al.
Published: (2024)

Pharmacoeconomic analysis of anti-angiogenic therapy for diabetic macular edema
by: S. V. Nedogoda, et al.
Published: (2019)

Multicriteria analysis of the assortment of innovative drugs in oncohematology as a tool for supporting decision-making in the field of drug provision
by: S. V. Nedogoda, et al.
Published: (2018)

Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria
by: S. V. Nedogoda, et al.
Published: (2019)

CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: S. V. Nedogoda, et al.
Published: (2017)

Dapagliflozin versus empagliflozin in patients with chronic kidney disease
by: Hilmi Alnsasra, et al.
Published: (2023)

Economic Burden of Hypertension in the Russian Federation
by: Yu. A. Balanova, et al.
Published: (2020)

ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2018)

Clinical and economic efficiency of treatment with dapagliflozin of patients with type 2 diabetes mellitus in Russian health care conditions
by: S. K. Zyryanov, et al.
Published: (2020)

Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2
by: S. V. Nedogoda, et al.
Published: (2020)

Dupilumab in the treatment of severe non-control broncial asthma - economic aspects
by: A. S. Salasyuk, et al.
Published: (2019)

ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016
by: A. N. Kontsevaya, et al.
Published: (2018)

Social-economic burden of severe atopic dermatitis in the Russian Federation
by: I. S. Krysanov, et al.
Published: (2020)

Socio-economic burden of COVID-19 in the Russian Federation
by: A. S. Kolbin, et al.
Published: (2020)

Case report of leprosy in the Russian Federation
by: Alexey A. Kubanov, et al.
Published: (2023)

Social-economic burden of Pompe disease with late onset in the Russian Federation
by: A. S. Kolbin, et al.
Published: (2019)

Use of dapagliflozin in patients with advanced diabetic kidney disease
by: Hyun Sun Park, et al.
Published: (2018)

SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION
by: A. E. Platonov, et al.
Published: (2015)

SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2016)

SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2016)

Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018)

Transgender population in the Russian Federation: diversity and trends
by: Nadezhda V. Solovieva, et al.
Published: (2023)

Socio-economic burden of atrial fibrillation in the Russian Federation: dynamics over 12 years
by: A. P. Kasimova, et al.
Published: (2023)

Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice
by: Jin Joo Cha, et al.
Published: (2024)

A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
by: Kim HC, et al.
Published: (2023)

REALIZATION OF DOCTORAL TRAINING PROGRAMS BASED ON THE FEDERAL LAW «ON EDUCATION IN THE RUSSIAN FEDERATION»
by: Irina A. Mosicheva, et al.
Published: (2022)

Experience of using telemedicine technologies in healthcare systems of foreign countries and the Russian Federation: systematic review
by: O. A. Volkova, et al.
Published: (2022)

Abortion: special statistics in the federal districts of Russian Federation
by: O S Filippov, et al.
Published: (2016)

Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
by: I. S. Krysanov
Published: (2018)

Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation
by: D. G. Shchurov, et al.
Published: (2021)

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice
by: M. M. Loukianov, et al.
Published: (2020)

Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review
by: Meiyu Wu, et al.
Published: (2022)

Efficacy of Tuberculosis Treatment in Patients with Drug-Resistant Tuberculosis with the Use of Bedaquiline: The Experience of the Russian Federation
by: Anna Starshinova, et al.
Published: (2022)

Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use
by: António Cabral Lopes, et al.
Published: (2024)

Population analysis and spring count of the number of geese in the Amur region (Russian Federation)
by: Aleksandr Senchik, et al.
Published: (2022)

Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation
by: Yu. A. Balanova, et al.
Published: (2018)

A rare form of leishmaniasis, identified in the Russian Federation
by: Olga G. Artamonova, et al.
Published: (2023)